Keywords: Licensing, Merck KGaA, Immunovaccine, EMD-640744, Novartis, Ablynx, Roche, Qiagen, PI3K

Batch of licensing deals announced by Merck KGaA, Novartis and Roche

Article | 13 July 2010

Print This

Three European drug majors announced- in and out-licensing deals yesterday, although on a much smaller scale than some of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in